Literature DB >> 9732736

[Immunoglobulin therapy in Gilles de la Tourette syndrome].

N Müller1, M Riedel, A Erfurth, H J Möller.   

Abstract

It has known for a long time that Sydenham's chorea and tics, as seen in Gilles de la Tourette's syndrome (GTS), are phenomenologically very similar. Tics may occur as symptoms of acute Sydenham's chorea or persist over years as residual symptoms. Investigating of children suffering from GTS, including obsessive-compulsive symptoms, have provided signs of a poststreptococcal autoimmune process but also shown that treatment based on immunological interventions has been effective. We treated a 14-year-old boy showing all diagnostic criteria of GTS, familial susceptibility, and an increase in the antibody titer of streptococcal antigens with 75 immunoglobulins i.v. over 5 days. Response to this therapy was good regarding motor tics, vocal tics, and behavioral symptoms such as disturbed impulse control which still persisted after 9 months. These findings and the successful therapy underline reports of the literature and point to a pathogenetic mechanism of an immunologically triggered disturbance of the striatal dopaminergic system, at least in a subgroup of GTS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9732736     DOI: 10.1007/s001150050216

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

Review 1.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children.

Authors:  V P Zykov; A Yu Shcherbina; E B Novikova; T V Shvabrina
Journal:  Neurosci Behav Physiol       Date:  2009-09

Review 4.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

5.  The Relationship between Tourette's Syndrome and Infections.

Authors:  Daniela L Krause; Norbert Müller
Journal:  Open Neurol J       Date:  2012-11-16

Review 6.  Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

Authors:  Norbert Müller
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.